CONCLUSION
Our study has shown an association between higher MAGE and women who
subsequently develop GDM. Our study demonstrated the use of the CGM
sensor during pregnancy to be a promising, and applicable technology in
gestational glucose profiling to determine GV and GC parameters in a
convenient, and pain-free manner. Early pregnancy presents a unique
opportunity for early GDM risk stratification to allow for earlier
lifestyle interventions to prevent adverse maternal and child health
outcomes 27. More future studies are required on a
larger scale to eventually establish a gold standard metric using
CGM-derived data in terms of predicting the risk for GDM development.